Archives: Agenda

• Addressing logistical challenges in clinical trials for blood sample processing
• Implementing solutions to stabilise biomarkers at collection and simplify workflows

As financial institutions move from experimentation to enterprise-wide deployment, the AI agenda is becoming more complex and more consequential. We examine the key trends shaping how AI is being adopted, governed and scaled across financial services, from the rise of agentic systems and evolving regulatory expectations, to the growing pressure to demonstrate real commercial value. Drawing on GlobalData’s latest research, we explore how leading firms are prioritising investment, where momentum is building, and where risks are emerging. This session provides a clear view of what leaders need to focus on now to stay competitive, compliant and credible as AI matures.

Best 3 LinkedIn posts from day 1 with hashtag #CTO and @Clinical Trials in Oncology Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!